| Market Cap | 42.26M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -19.35M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -8.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -35.00% |
| Dividend | N/A | Price/Book | 1.29 | EPS next 5Y | - | 52W High Chg | -66.00% |
| Recommedations | - | Quick Ratio | 4.38 | Shares Outstanding | 12.65M | 52W Low Chg | 21.00% |
| Insider Own | - | ROA | -26.61% | Shares Float | 10.76M | Beta | - |
| Inst Own | 2.24% | ROE | -80.18% | Shares Shorted/Prior | 24.53K/11.89K | Price | 3.34 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 34,073 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 115,786 | Change | -1.47% |
MeaTech 3D Ltd., a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter. The company develops a three-dimensional bioprinter to deposit layers of differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. It intends to license its production technology; provide associated products, such as cell lines, printheads, bioreactors, and incubators; and offer services, such as technology implementation, training, and engineering support directly and through contractors to food processing and food retail companies. The company is headquartered in Rehovot, Israel.
